Skip to main content
logo
iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.200
0.00 (0.00%)
Sep 15, 2026, 3:04 PM EDT - Market open

iBio, Inc. Financials Overview

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
0.10.10.40.23-1.88
Revenue Growth
-75.00%-75.00%77.78%---20.54%
Gross Profit
0.10.10.40.23-1.88
Operating Income
-30.14-30.14-18.6-16.63-28.78-29.7
Net Income
-33.04-33.04-18.38-24.91-65.01-50.39
Earnings Per Share
-0.32-0.32-1.75-6.50-106.23-115.56
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
88.0488.048.5814.214.333.52
Total Debt
2.22.23.574.8217.4825.77
Net Cash (Debt)
85.8485.845.019.39-13.177.76
Net Cash Growth
1613.39%1613.39%-46.62%---87.93%
Net Cash Per Share
0.820.820.482.45-21.5317.78

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-23.22-23.22-15.3-18.55-30.44-37.48
Capital Expenditures
-0.58-0.58-0.02-0.21-6.43-7.33
Free Cash Flow
-23.8-23.8-15.32-18.76-36.87-44.81
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
100.00%100.00%100.00%100.00%-100.00%
Operating Margin
-30138.00%-30138.00%-4650.50%-7392.89%--1576.27%
Pretax Margin
-33044.00%-33044.00%-4594.25%-6863.56%--1566.51%
Profit Margin
-33044.00%-33044.00%-4594.25%-11069.78%--2674.68%
FCF Margin
-23796.00%-23796.00%-3830.00%-8339.56%--2378.45%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
771.69869.3830.9480.87-30.57